Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andrea Pierleoni

Showing results (11-20 of 13) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 13 results.
Oncotarget|December 10, 2017
TCTN2: a novel tumor marker with oncogenic propertiesDavid Cano-Rodriguez, Susanna Campagnoli, Alberto Grandi, et al.
Nucleic Acids Research|November 16, 2020
Open Targets Platform: supporting systematic drug-target identification and prioritisationDavid Ochoa, Andrew Hercules, Miguel Carmona, et al.
Nucleic Acids Research|December 1, 2016
Open Targets: a platform for therapeutic target identification and validationGautier Koscielny, Peter An, Denise Carvalho-Silva, et al.
Pageof 2

Showing results (11-20 of 13) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 13 results.
Oncotarget|December 10, 2017
TCTN2: a novel tumor marker with oncogenic propertiesDavid Cano-Rodriguez, Susanna Campagnoli, Alberto Grandi, et al.
Nucleic Acids Research|November 16, 2020
Open Targets Platform: supporting systematic drug-target identification and prioritisationDavid Ochoa, Andrew Hercules, Miguel Carmona, et al.
Nucleic Acids Research|December 1, 2016
Open Targets: a platform for therapeutic target identification and validationGautier Koscielny, Peter An, Denise Carvalho-Silva, et al.
Pageof 2